Cell Line : MHH-NB-11
Cellosaurus Index : CVCL_1412
Cellosaurus ID : MHH-NB-11
CCLE Name
: MHHNB11_AUTONOMIC_GANGLIA
CTRP2 Name
: MHHNB11
GDSC1 Name
, GDSC2 Name
: MHH-NB-11
Cancer Type : autonomic_ganglia
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| MHH-NB-11 | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| MHH-NB-11 | A-443654 | GDSC1 | 0.0040 | 1.0240 |
|
| MHH-NB-11 | A-770041 | GDSC1 | 0.0200 | 5.1200 |
|
| MHH-NB-11 | AA-COCF3 | CTRP2 | 0.0081 | 270.0000 |
|
| MHH-NB-11 | ABT737 | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| MHH-NB-11 | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | Afatinib | GDSC1,GDSC2 | 0.0020 | 4.0000 |
|
| MHH-NB-11 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| MHH-NB-11 | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| MHH-NB-11 | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| MHH-NB-11 | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| MHH-NB-11 | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| MHH-NB-11 | Alisertib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-NB-11 | Alpelisib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| MHH-NB-11 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| MHH-NB-11 | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| MHH-NB-11 | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| MHH-NB-11 | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-NB-11 | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| MHH-NB-11 | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| MHH-NB-11 | Axitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | AZ628 | GDSC1 | 0.0156 | 4.0000 |
|
| MHH-NB-11 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| MHH-NB-11 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-NB-11 | AZD4547 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | AZD5582 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | AZD6482 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | AZD6738 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | AZD7762 | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| MHH-NB-11 | AZD8055 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | AZD8186 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| MHH-NB-11 | BEC | CTRP2 | 0.0081 | 270.0000 |
|
| MHH-NB-11 | Belinostat | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Bexarotene | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BI-2536 | GDSC1,GDSC2,CTRP2 | 0.0005 | 33.0000 |
|
| MHH-NB-11 | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | BIBR-1532 | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| MHH-NB-11 | Bicalutamide | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| MHH-NB-11 | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BIX-01294 | CTRP2 | 0.0160 | 33.0000 |
|
| MHH-NB-11 | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | Bleomycin | GDSC1 | 0.2500 | 64.0000 |
|
| MHH-NB-11 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BMS-345541 | GDSC1,GDSC2 | 0.0100 | 16.0000 |
|
| MHH-NB-11 | BMS-509744 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | BMS-536924 | GDSC1,GDSC2,CTRP2 | 0.0011 | 18.0000 |
|
| MHH-NB-11 | BMS-754807 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Bortezomib | GDSC1,GDSC2,CTRP2 | 0.0000 | 0.1300 |
|
| MHH-NB-11 | Bosutinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| MHH-NB-11 | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 0.1900 |
|
| MHH-NB-11 | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K03536150 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K03911514 | CTRP2 | 0.0020 | 17.0000 |
|
| MHH-NB-11 | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K11533227 | CTRP2 | 0.0020 | 0.2600 |
|
| MHH-NB-11 | BRD-K13185470 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| MHH-NB-11 | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K27224038 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K27986637 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K30019337 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K41334119 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K48334597 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K49290616 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K51490254 | CTRP2 | 0.0020 | 0.2600 |
|
| MHH-NB-11 | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K75293299 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K78574327 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K84807411 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K86535717 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | BRD-K96431673 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K96970199 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| MHH-NB-11 | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-NB-11 | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-NB-11 | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| MHH-NB-11 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | BX795 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Cabozantinib | GDSC1 | 0.0200 | 5.1200 |
|
| MHH-NB-11 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| MHH-NB-11 | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| MHH-NB-11 | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | CCT-018159 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-NB-11 | CD-437 | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-NB-11 | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| MHH-NB-11 | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | CGP-082996 | GDSC1 | 0.0200 | 5.1200 |
|
| MHH-NB-11 | CGP-60474 | GDSC1 | 0.0010 | 0.2560 |
|
| MHH-NB-11 | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| MHH-NB-11 | CHIR-99021 | GDSC1,GDSC2,CTRP2 | 0.0024 | 80.0000 |
|
| MHH-NB-11 | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| MHH-NB-11 | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| MHH-NB-11 | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| MHH-NB-11 | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| MHH-NB-11 | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | CIL41 | CTRP2 | 0.0049 | 160.0000 |
|
| MHH-NB-11 | cimetidine | CTRP2 | 0.0081 | 270.0000 |
|
| MHH-NB-11 | Cisplatin | GDSC1 | 0.0391 | 10.0000 |
|
| MHH-NB-11 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | CMK | GDSC1 | 0.0156 | 4.0000 |
|
| MHH-NB-11 | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-NB-11 | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| MHH-NB-11 | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| MHH-NB-11 | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Crizotinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-NB-11 | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| MHH-NB-11 | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| MHH-NB-11 | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| MHH-NB-11 | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| MHH-NB-11 | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | cyanoquinoline 11 | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-NB-11 | Cyclopamine | GDSC1 | 0.0625 | 16.0000 |
|
| MHH-NB-11 | Cyclophosphamide | GDSC2,CTRP2 | 0.0041 | 130.0000 |
|
| MHH-NB-11 | Cytarabine | GDSC1 | 0.0078 | 2.0000 |
|
| MHH-NB-11 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Dabrafenib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| MHH-NB-11 | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| MHH-NB-11 | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| MHH-NB-11 | Daporinad | GDSC2,CTRP2 | 0.0000 | 1.0000 |
|
| MHH-NB-11 | darinaparsin | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Dasatinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-NB-11 | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| MHH-NB-11 | Docetaxel | GDSC1,GDSC2 | 0.0000 | 0.0125 |
|
| MHH-NB-11 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-NB-11 | Doramapimod | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Doxorubicin | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-NB-11 | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | ELCPK | CTRP2 | 0.0000 | 0.4000 |
|
| MHH-NB-11 | Elesclomol | GDSC1,GDSC2 | 0.0002 | 0.2000 |
|
| MHH-NB-11 | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| MHH-NB-11 | Entinostat | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| MHH-NB-11 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Erlotinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-NB-11 | Etoposide | GDSC1,CTRP2 | 0.0009 | 28.0000 |
|
| MHH-NB-11 | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | Fedratinib | GDSC1,CTRP2 | 0.0011 | 37.0000 |
|
| MHH-NB-11 | FGIN-1-27 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| MHH-NB-11 | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| MHH-NB-11 | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-NB-11 | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Foretinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| MHH-NB-11 | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | Fulvestrant | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-NB-11 | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| MHH-NB-11 | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Gefitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Gemcitabine | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | GNF-2 | GDSC1 | 0.0050 | 1.2800 |
|
| MHH-NB-11 | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| MHH-NB-11 | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 5.0000 |
|
| MHH-NB-11 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | GSK269962A | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MHH-NB-11 | GSK319347A | GDSC1 | 0.0195 | 5.0000 |
|
| MHH-NB-11 | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-NB-11 | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| MHH-NB-11 | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-NB-11 | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| MHH-NB-11 | GW843682X | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| MHH-NB-11 | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | I-BET-762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | IC-87114 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Idelalisib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Imatinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | IOX2 | GDSC2 | 0.0005 | 0.5000 |
|
| MHH-NB-11 | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| MHH-NB-11 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-NB-11 | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | isoliquiritigenin | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MHH-NB-11 | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| MHH-NB-11 | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-NB-11 | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| MHH-NB-11 | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-NB-11 | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 0.1900 |
|
| MHH-NB-11 | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 0.1900 |
|
| MHH-NB-11 | JQ1 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| MHH-NB-11 | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | JW-7-52-1 | GDSC1 | 0.0047 | 1.2000 |
|
| MHH-NB-11 | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| MHH-NB-11 | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | KU-55933 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-NB-11 | Lapatinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| MHH-NB-11 | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | LCL161 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| MHH-NB-11 | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| MHH-NB-11 | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| MHH-NB-11 | LGK974 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | Linifanib | GDSC1 | 0.0040 | 1.0240 |
|
| MHH-NB-11 | Linsitinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-NB-11 | Luminespib | GDSC1,GDSC2 | 0.0003 | 0.2560 |
|
| MHH-NB-11 | LY-2157299 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-NB-11 | Masitinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| MHH-NB-11 | Methotrexate | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| MHH-NB-11 | MG-132 | GDSC1,GDSC2 | 0.0039 | 4.0000 |
|
| MHH-NB-11 | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| MHH-NB-11 | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Mirin | GDSC2 | 0.1001 | 100.0000 |
|
| MHH-NB-11 | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| MHH-NB-11 | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| MHH-NB-11 | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | MK-1775 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | MK-2206 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-NB-11 | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| MHH-NB-11 | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| MHH-NB-11 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| MHH-NB-11 | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| MHH-NB-11 | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | myriocin | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Navitoclax | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Nilotinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| MHH-NB-11 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| MHH-NB-11 | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| MHH-NB-11 | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| MHH-NB-11 | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | NSC632839 | CTRP2 | 0.0160 | 33.0000 |
|
| MHH-NB-11 | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| MHH-NB-11 | Nutlin-3a | GDSC1,GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| MHH-NB-11 | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | NVP-TAE684 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Obatoclax Mesylate | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Olaparib | GDSC1,GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| MHH-NB-11 | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| MHH-NB-11 | OSI-027 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | OSI-930 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-NB-11 | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| MHH-NB-11 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| MHH-NB-11 | Oxaliplatin | GDSC2,CTRP2 | 0.0100 | 66.0000 |
|
| MHH-NB-11 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | PAC-1 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Paclitaxel | GDSC1,GDSC2,CTRP2 | 0.0001 | 66.0000 |
|
| MHH-NB-11 | Palbociclib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| MHH-NB-11 | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Panobinostat | GDSC1 | 0.0040 | 1.0240 |
|
| MHH-NB-11 | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Parthenolide | GDSC1 | 0.0195 | 5.0000 |
|
| MHH-NB-11 | Pazopanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | PD0325901 | GDSC1,GDSC2 | 0.0010 | 2.5000 |
|
| MHH-NB-11 | PD173074 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| MHH-NB-11 | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| MHH-NB-11 | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| MHH-NB-11 | Pevonedistat | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| MHH-NB-11 | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | PF-4708671 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| MHH-NB-11 | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | PFI-1 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | PFI3 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | PHA-665752 | GDSC1 | 0.0078 | 2.0000 |
|
| MHH-NB-11 | PHA-793887 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| MHH-NB-11 | PI-103 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Pictilisib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| MHH-NB-11 | PIK-93 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | Piperlongumine | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | PLX-4720 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| MHH-NB-11 | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| MHH-NB-11 | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| MHH-NB-11 | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-NB-11 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| MHH-NB-11 | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| MHH-NB-11 | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Pyrimethamine | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | QS11 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Quizartinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Rapamycin | GDSC1,GDSC2,CTRP2 | 0.0001 | 33.0000 |
|
| MHH-NB-11 | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Regorafenib | CTRP2 | 0.0320 | 66.0000 |
|
| MHH-NB-11 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| MHH-NB-11 | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | Rucaparib | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-NB-11 | Ruxolitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | S-Trityl-L-cysteine | GDSC1 | 0.0200 | 5.1200 |
|
| MHH-NB-11 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| MHH-NB-11 | Salubrinal | GDSC1 | 0.0625 | 16.0000 |
|
| MHH-NB-11 | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-NB-11 | Saracatinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-NB-11 | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | SB505124 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| MHH-NB-11 | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| MHH-NB-11 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-NB-11 | Seliciclib | GDSC1 | 0.0625 | 16.0000 |
|
| MHH-NB-11 | Selisistat | GDSC1,CTRP2 | 0.0024 | 20.0000 |
|
| MHH-NB-11 | Selumetinib | GDSC1,GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| MHH-NB-11 | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MHH-NB-11 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MHH-NB-11 | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 10.0000 |
|
| MHH-NB-11 | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MHH-NB-11 | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Sepantronium bromide | GDSC1,GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| MHH-NB-11 | Serdemetan | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | SGC0946 | GDSC2 | 0.0005 | 0.5000 |
|
| MHH-NB-11 | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| MHH-NB-11 | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| MHH-NB-11 | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | sitagliptin | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-NB-11 | SL0101 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | SN-38 | GDSC1,GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| MHH-NB-11 | SNS-032 | CTRP2 | 0.0020 | 33.0000 |
|
| MHH-NB-11 | SNX-2112 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MHH-NB-11 | Sorafenib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Sphingosine Kinase 1 Inhibitor II | GDSC1 | 0.0100 | 2.5600 |
|
| MHH-NB-11 | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| MHH-NB-11 | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | SU11274 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Sunitinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | Talazoparib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Tamoxifen | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Tanespimycin | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 0.0650 |
|
| MHH-NB-11 | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Taselisib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Telomerase Inhibitor IX | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Temozolomide | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| MHH-NB-11 | Teniposide | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | TGX221 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| MHH-NB-11 | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| MHH-NB-11 | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| MHH-NB-11 | tipifarnib-P2 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Tivozanib | GDSC1,CTRP2 | 0.0005 | 33.0000 |
|
| MHH-NB-11 | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | Tozasertib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| MHH-NB-11 | TPCA-1 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Trametinib | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-NB-11 | Tretinoin | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| MHH-NB-11 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| MHH-NB-11 | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| MHH-NB-11 | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Tubastatin A | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | TW 37 | CTRP2 | 0.0010 | 8.3000 |
|
| MHH-NB-11 | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | UNC0638 | GDSC1,CTRP2 | 0.0010 | 40.0000 |
|
| MHH-NB-11 | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 0.1300 |
|
| MHH-NB-11 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| MHH-NB-11 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-NB-11 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Veliparib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| MHH-NB-11 | Vinblastine | GDSC1 | 0.0004 | 0.1000 |
|
| MHH-NB-11 | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| MHH-NB-11 | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| MHH-NB-11 | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| MHH-NB-11 | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Vorinostat | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0320 | 66.0000 |
|
| MHH-NB-11 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 0.1300 |
|
| MHH-NB-11 | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| MHH-NB-11 | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| MHH-NB-11 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | WH-4-023 | GDSC1 | 0.0200 | 5.1200 |
|
| MHH-NB-11 | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | Wnt-C59 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | WZ-1-84 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| MHH-NB-11 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | WZ8040 | CTRP2 | 0.0020 | 0.2600 |
|
| MHH-NB-11 | XAV939 | GDSC2 | 0.0050 | 5.0000 |
|
| MHH-NB-11 | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| MHH-NB-11 | XMD8-85 | GDSC1 | 0.0312 | 8.0000 |
|
| MHH-NB-11 | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | YK-4-279 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MHH-NB-11 | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| MHH-NB-11 | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| MHH-NB-11 | Z-LLNle-CHO | GDSC1 | 0.0100 | 2.5600 |
|
| MHH-NB-11 | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| MHH-NB-11 | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MHH-NB-11 | ZSTK474 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC